Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News GeoVax Labs Inc GOVX

Healthcare Biotechnology
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using proprietary platforms. Its product pipeline includes ongoing human clinical trials for a Covid-19 vaccine and a gene-directed therapy against advanced head and neck cancers. Its additional research and development programs include... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:GOVX)

GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia

GlobeNewswire 2 days ago

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 9 days ago

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

GlobeNewswire November 5, 2024

GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

GlobeNewswire October 2, 2024

GeoVax to Participate in Upcoming Investor Conferences in September

GlobeNewswire September 3, 2024

GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market

GlobeNewswire August 28, 2024

Registration is Now Open for Tribe Public's Webinar Event "Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Lab's CEO

GlobeNewswire August 21, 2024

GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market

GlobeNewswire August 20, 2024

GeoVax to Present at the Emerging Growth Conference on August 21, 2024

GlobeNewswire August 15, 2024
View More News ››

Opinion & Analysis (NDAQ:GOVX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:GOVX)

GeoVax Announces Positive Interim Data Review for Phase 2 Cl

JUST IN: $GOVX GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with...
whytestocks - 2 days ago

GeoVax to Participate in the 3rd Annual ROTH Healthcare Oppo

BREAKING NEWS: $GOVX GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities ConferenceATLANTA, Ga., Oct. 02, 2024 (GLOBE...
whytestocks - October 2, 2024

Presenting on the Emerging Growth Conference 74 Day 1 on Aug

NEWS: $GOVX Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register NowMIAMI, Aug. 20, 2024 (GLOBE NEWSWIRE...
whytestocks - August 20, 2024

BUY BUY BUY BUY BUY

Officier and directorat David a.dodd buys 8000 shares on 09 08 24
Nibinator - August 16, 2024

GeoVax to Present at the Emerging Growth Conference on Augus

Just In: $GOVX GeoVax to Present at the Emerging Growth Conference on August 21, 2024Company to Discuss Recent Mpox Developments as Well...
whytestocks - August 15, 2024

BUY BUY BUY BUY BUY

W.H.O. DEClares state of emergency in africa on monkey pox
Nibinator - August 15, 2024
View more Bullboard ››

Coelacanth Energy Inc.

Coelacanth Energy Inc.

Coelacanth Energy Inc. is a Montney-focused oil and natural gas exploration and development company, with lands located in ...
View More »